Bioton Zasób 1
  • Company
    • Diabetology expert
    • HISTORY AND MILESTONES
    • BIOTON WORLDWIDE
    • ABOUT US
  • ESG Bioton
    • ESG Initiatives
    • News
  • Patient
    • Diabetes
    • Insulin
    • Products
      • DRUGS
      • MEDICAL DEVICES
    • Treatment of diabetes
  • R&D
    • Our experts
    • R&D projects
    • Research facilities
    • Processes and teams
  • Production
    • Factory
    • Production capacity
    • Production processes
    • Quality
    • Environmental protection
  • Careers
    • Discover bioton
    • Recruitment
  • Investor
    • Results centre
      • Reports
      • General meetings
      • Calendar of events
    • Company management
    • Corporate documents
    • Contact for investors
  • Newsroom
    • News
  • Company
    • Diabetology expert
    • HISTORY AND MILESTONES
    • BIOTON WORLDWIDE
    • ABOUT US
  • ESG Bioton
    • ESG Initiatives
    • News
  • Patient
    • Diabetes
    • Insulin
    • Products
      • DRUGS
      • MEDICAL DEVICES
    • Treatment of diabetes
  • R&D
    • Our experts
    • R&D projects
    • Research facilities
    • Processes and teams
  • Production
    • Factory
    • Production capacity
    • Production processes
    • Quality
    • Environmental protection
  • Careers
    • Discover bioton
    • Recruitment
  • Investor
    • Results centre
      • Reports
      • General meetings
      • Calendar of events
    • Company management
    • Corporate documents
    • Contact for investors
  • Newsroom
    • News
  • PL
LinkedIn Bioton LinkedIn Bioton
  • PL
  • News

    Jeremy J Launders appointed
    as the new President of
    the Management Board of BIOTON S.A.

    On 30 October 2020 the Company Supervisory Board appointed Jeremy Launders as President of Bioton S.A. Jeremy Launders is a leader with extensive experience (...)
    6 November 2020
    more
    Życie bez cukrzycy – czy można zapobiec rozwojowi choroby?

    A life without diabetes – can the disease be prevented?

    Ongoing research is happening to understand factors that could influence the destruction of insulin producing cells in type 1 diabetes. However, for type 2 (...)
    29 June 2020
    more

    We are strongly committed
    to delivering insulin to our patients

    According to the latest data from IDF Diabetes Atlas, 463 million people suffer from diabetes worldwide. An estimated 232 million remain undiagnosed. The data (...)
    27 May 2020
    more

    Coronavirus and diabetes
    – guidelines for patients
    with diabetes

    In the past weeks we have all been asking ourselves whether or not we are in the risk group more vulnerable to COVID-19 and (...)
    22 April 2020
    more

    Coronavirus – safety measures applied at BIOTON S.A.

    Our company operates in the very important area of healthcare, which is why we treat safety very seriously. As a result of the worrisome (...)
    30 March 2020
    more

    The future of treating diabetes – report from the 14th “What’s New in Diabetes” conference

    What is the future of treating diabetes? What new solutions are available in term of therapy? How to avoid hypoglycaemia in insulin-treated patients? These (...)
    22 January 2020
    more
    « 1 … 4 5 6 7 »
    • Company
    • Patient
    • R&D
    • Production
    • Careers
    • Investor
    • Newsroom
    Bioton

    BIOTON S.A.

    Macierzysz, ul. Poznańska 12

    05-850 Ożarów Mazowiecki

    tel. +48 (22) 721 40 00

    fax +48 (22) 721 13 33

    bioinfo@bioton.com

    LinkedIn Bioton
    • Terms of Use
    • Cookies Policy
    • Privacy policy
    • Contact
    • Change cookie settings

    Copyright 2025 © All rights reserved

    Projekt i realizacja: copuz.com